DWM
RPRX icon

Dogwood Wealth Management’s Royalty Pharma RPRX Stock Holding History

Dogwood Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.33K Buy
95
+30
+46% +$1.56K ﹤0.01% 499
2026
Q1 		$3.12K Buy
65
+44
+210% +$1.93K ﹤0.01% 569
2025
Q4 		$811 Buy
21
+17
+425% +$648 ﹤0.01% 636
2025
Q3 		$141 Buy
+4
New +$145 ﹤0.01% 710

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dogwood Wealth Management's RPRX Position: Q2 2026 in Review

Dogwood Wealth Management increased its Royalty Pharma (RPRX) stake by 46% in Q2 2026, buying an estimated $1.56K and bringing the position to 95 shares worth $5.33K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Dogwood Wealth Management first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Dogwood Wealth Management held 95 shares of Royalty Pharma worth $5.33K as of Q2 2026.
  • Dogwood Wealth Management bought 30 Royalty Pharma shares in Q2 2026, an estimated $1.56K.
  • Royalty Pharma made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #499 holding.
  • Dogwood Wealth Management first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.